trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide

C48H56N8O6S — CID 175664278

IUPACtrans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide
SMILESCO[C@@H](C)c1ncc(N2CCOCC2)cc1-c1c2c3cc(cc4c3n1CCC4)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1c1cccnc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C48H56N8O6S/c1-28(60-4)42-36(20-32(25-50-42)54-14-16-61-17-15-54)44-37-23-48(2,3)27-62-47(59)38-10-7-13-56(53-38)46(58)39(52-45(57)35-21-33(35)30-8-5-11-49-24-30)22-41-51-40(26-63-41)31-18-29-9-6-12-55(44)43(29)34(37)19-31/h5,8,11,18-20,24-26,28,33,35,38-39,53H,6-7,9-10,12-17,21-23,27H2,1-4H3,(H,52,57)/t28-,33+,35-,38-,39-/m0/s1
InChIKeyQWPUUNPCUHZAST-PIAMFLESSA-N
MW873.09 g/mol
LogP6.16
Rot. Bonds7

About trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide

trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide (PubChem CID 175664278) has the molecular formula C48H56N8O6S and a molecular weight of 873.09 g/mol. Its IUPAC name is trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide.

Molecular Properties

Compound Nametrans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide
PubChem CID175664278
Molecular FormulaC48H56N8O6S
Molecular Weight873.09 g/mol
Exact Mass872.40
IUPAC Nametrans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide
SMILESCO[C@@H](C)c1ncc(N2CCOCC2)cc1-c1c2c3cc(cc4c3n1CCC4)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1c1cccnc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2
InChIInChI=1S/C48H56N8O6S/c1-28(60-4)42-36(20-32(25-50-42)54-14-16-61-17-15-54)44-37-23-48(2,3)27-62-47(59)38-10-7-13-56(53-38)46(58)39(52-45(57)35-21-33(35)30-8-5-11-49-24-30)22-41-51-40(26-63-41)31-18-29-9-6-12-55(44)43(29)34(37)19-31/h5,8,11,18-20,24-26,28,33,35,38-39,53H,6-7,9-10,12-17,21-23,27H2,1-4H3,(H,52,57)/t28-,33+,35-,38-,39-/m0/s1
InChIKeyQWPUUNPCUHZAST-PIAMFLESSA-N
XLogP6.16
TPSA153.04 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds7
Heavy Atoms63
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500873.09
LogP ≤ 56.16
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide?
The IUPAC name of trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide (CID 175664278) is trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide.
What is the SMILES notation for trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide?
The canonical SMILES for trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide is CO[C@@H](C)c1ncc(N2CCOCC2)cc1-c1c2c3cc(cc4c3n1CCC4)-c1csc(n1)C[C@H](NC(=O)[C@H]1C[C@@H]1c1cccnc1)C(=O)N1CCC[C@H](N1)C(=O)OCC(C)(C)C2.
What is the InChIKey of trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide?
The InChIKey is QWPUUNPCUHZAST-PIAMFLESSA-N. The full InChI is InChI=1S/C48H56N8O6S/c1-28(60-4)42-36(20-32(25-50-42)54-14-16-61-17-15-54)44-37-23-48(2,3)27-62-47(59)38-10-7-13-56(53-38)46(58)39(52-45(57)35-21-33(35)30-8-5-11-49-24-30)22-41-51-40(26-63-41)31-18-29-9-6-12-55(44)43(29)34(37)19-31/h5,8,11,18-20,24-26,28,33,35,38-39,53H,6-7,9-10,12-17,21-23,27H2,1-4H3,(H,52,57)/t28-,33+,35-,38-,39-/m0/s1.
What are the key properties of trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide?
trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide has a molecular weight of 873.09 g/mol, XLogP of 6.16, 7 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for trans-(1S,2S)-N-[(7S,13S)-20-[2-[(1S)-1-methoxyethyl]-5-morpholin-4-yl-3-pyridinyl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,30,31-tetrazahexacyclo[23.3.1.12,5.19,13.019,27.021,26]hentriaconta-1(29),2,5(31),19,25,27-hexaen-7-yl]-2-pyridin-3-ylcyclopropane-1-carboxamide is sourced from PubChem (CID 175664278), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).